Nine-year-old female great Dane, (Canis familiaris).The dog
presented for clinical evaluation of progressive neurologic disease of two
months duration and was diagnosed with canine cognitive dysfunction (CCD).
Clinical signs include incoordination, weakness, lethargy, anorexia and
locomotion difficulties. The animal was treated with antioxidants, tramadol,
and propentophylin (vasodilator). Six months later, the dogs condition
deteriorated with the onset of seizures and was euthanized.
dog was in good body condition. There were no significant gross lesions of the
thoracic, abdominal viscera, or eyes. In the left brain hemisphere, there was a
2x2.5 cm soft, grayish-tan, fixed mass with a velvet surface that protrudes
from the fontal lobe. Following formalin fixation and sectioning, the mass
extended 1cm into the gray matter of the brain parenchyma.
is focally infiltration of the gray matter by a sharply demarcated but
unencapsulated, multinodular, hypercellular mass compose by neoplastic cells
arranged in concentric whorls separate into well-demarcated lobules by a
delicate fibrous stroma. Neoplastic cells have variably distinct borders with
varying amounts of eosinophilic microvacuolar cytoplasm, oval to spindle-shaped
vesicular nuclei with finely stippled chromatin and predominantly one large
open-faced nucleoli. Mitoses are rare with less than one mitotic figure per
high power field. Occasionally necrotic foci are present. There is no evidence of
vascular invasion. Brain tissue
immediately adjacent to the mass is markedly compressed, and there are few
lymphocytes and some pigment (hemosiderin) laden macrophages.
Brain: Meningioma, transitional.
laboratory analysis performed.
incidence of brain tumors in canine may approach 3.0%. It has been reported
that meningiomas are the most common intracranial tumors in dogs, followed by
glial tumors (astrocytoma and oligodendroglioma).9 Meningioma is
also the most common type of intracranial tumor in the cat. Meningiomas are
rare in cattle and not recorded in horses.10 Neoplastic cells arise
from the cap cells covering the arachnoid, particularly at the point where they
project into the venous sinuses4 and pia mater of the nervous
Older dogs may have a predisposition for primary brain tumors. Meningiomas occur in dolichocephalic breeds, especially German shepherds, golden retrievers and Labrador retrievers, with no consistent sex predisposition.7,9 Meningiomas may be present especially in the rostral cerebrum for a prolonged period before clinical signs of intracranial disease become obvious to the owner. Further, owners may attribute more subtle signs of forebrain disease (such as pacing or mentation change) to the normal aging process in a geriatric pet.5 The majority of animals with brain tumors present with a variety of mild or ill-defined neurological signs.
Canine meningiomas clinically display variable behavior that currently makes outcome difficult to predict. The behavior of canine meningiomas varies widely from case to case. Individual cases receiving basic therapies (corticosteroids and supportive therapies, such as anticonvulsant drugs) can have a much better outcome than other individuals that undergo more aggressive therapeutic regimens, such as surgery and post-operative radiation.1 Meningiomas usually grow as well-demarcated, often lobulated, firm, granular masses that usually have a broad-based or pedunculated attachment to the overlying meninges. Less commonly they can form plaque-like masses over the meninges.3,7 In some cases, canine meningioma shows a large cystic cavity or aggregation of severely vacuolated neoplastic cells as a consequence of ischemic events.7 Meningiomas are gray, sometimes yellow on cut surface, firm, and may be gritty. These tumors grow either by compression or, less commonly, by infiltration of the adjacent brain. In dogs, meningiomas are found commonly in the region of the olfactory bulb and frontal lobes, but can occur anywhere over the surface of the cerebral hemispheres. Supratentorial meningiomas are more common over the meninges of the convexities than in basilar sites.3
Due to the embryonic origin of the meninges, meningiomas exhibit highly variable morphological and immuno-phenotypic patterns.7 A classification based mainly on the WHO classification of human histological subtype describes the following histological patterns: meningothelial, fibroblastic, transitional (mixed), psammo-matous, angiomatous, papillary, granular cell, myxoid, and anaplastic. All of these histological variants except anaplastic (malignant) meningiomas have similar biologic behavior. They are slow growing and cause clinical signs by compression of underlying nervous tissue.5 Areas of chondroid, osseous, myxoid, and xanthomatous-like tissue can be found in the meningothelial and transitional forms.3 Most intracranial meningiomas are benign as indicated by low frequency of metastases and failure to invade the brain. By these criteria, ~ 2.5% are malignant and may metastasize. In contrast, extracranial meningiomas, which occur mainly in the paranasal region and orbit, are anaplastic and locally aggressive.7,9,10
In some cases, it can be difficult to distinguish meningiomas from other neoplasms, such as astrocytomas, oligo-dendrogliomas, metastatic carcinomas, germ cell tumors, and peripheral nerve sheath tumors. In these cases, a basic immuno-histochemical panel consisting of vimentin, CD34, and E-cadherin has been proposed for the characterisation of canine and feline meningiomas. 7 Meningiomas also stain sparse to moderate positively for cyto-keratin, NSE, and S-100 and negative for synaptophysin and GFAP.10
Meningioma, transitional, Great Dane, Canis familiaris.
The contributor provides an excellent review of the biologic behavior, gross
findings and, histopathologic patterns associated with the many different
classifications of meningiomas in dogs and cats. Meningiomas arise from the
meningo-thelial cells that line the arachnoid villi and cover the central
nervous system.2,3 As mentioned by the contributor, this is the most
common type of intracranial tumor in dogs and constitutes between 30-50% of all
primary intracranial tumors in this species.2,3 Additionally,
meningiomas account for approximately 60% of all primary intracranial neoplasms
in cats. The vast majority of meningiomas occur either within the cranium (82%)
or spinal cord (15%).3 Most intracranial meningiomas occur within
the olfactory bulb, but they have also been reported in the cerebral and
cerebellar convexity, parasagittal and parasellar area, cerebellopontine angle,
and foramen magnum.2,3 Conversely, only about 2-3% occur in the
retrobulbar or periorbital space.2 Readers are encouraged to review 2015 Wednesday Slide
Conference #20 Case 4 for an outstanding example
of a periorbital meningioma in a dog.
With the exception of the less common invasive and atypical grade II and malignant and anaplastic grade III types, meningiomas rarely invade into the neuroparenchyma.2,3 Instead, they will grow expansively within the cranium, as in this case, causing compression necrosis of the neuropil.2,3,8 Canine meningiomas bear a striking similarity in both histomorphology and biologic behavior to human meningiomas. As a result, there has been widespread application of the World Health Organization (WHO) classification scheme for humans in scientific reports of canine meningiomas.2-6,8 Conference participants discussed the nine histologic types of meningiomas, including: meningothelial, fibrous (fibroblastic), transitional (as in this case), psammomatous, angiomatous, papillary, granular cell, myxoid, and anaplastic. Other than the anaplastic type, all are slow growing and have a relatively benign biologic behavior.4,5,8 However, regardless of the histomorphology, in meningiomas in domestic animals, malignancy is still based on mitotic rate, cellularity, growth pattern, and tumor invasion into the underlying nervous tissue.2-5,8
Atypical, choroid, and clear cell types are subcategories of grade II meningiomas. Grade II meningiomas require 4 mitoses/ 10 high powered fields and at least three of the following features: of architectural pattern replaced by sheets of cells, small cell formation with a high nuclear: cytoplasmic ratio, nuclear atypia or macronuclei, hypercellularity, and spontaneous necrosis.2,3 The clear cell category is characterized by sheets of epithelial cells with abundant PAS positive cytoplasm, indicating glycogen accumulation. Grade III malignant meningiomas are comprised of papillary, anaplastic, and and rhomboid types and are characterized by extreme cellular anaplasia, >20 mitoses/10 high powered fields, necrosis, and neuroinvasion.3
Conference participants discussed doublecortin (DCX), Ki-67, E-cadherin, N-cadherin, and beta-catenin as potential immunohistochemical (IHC) stains that would help differentiate malignant from benign meningiomas. A relatively recent study in Veterinary Pathology used the previously mentioned IHC stains to predict the biologic behavior of meningiomas.4 The authors found that doublecortin (DCX), which is important in neuroblast migration during development, is highly expressed in invasive brain tumors, including malignant meningiomas. Additionally, Ki-67 staining, a standard marker of cell proliferation, is significantly higher in anaplastic meningiomas compared to benign varieties and is widely used to evaluate tumor grade and malignancy in humans.4 The authors also found that there is positive correlation between DCX and N-cadherin expression and conversely a negative correlation between E-cadherin and N-cadherin expression. Additionally decreased E-cadherin expression is associated with increased nuclear beta-catenin expression suggesting that decreased E-cadherin, increased N-cadherin, DCX expression, and nuclear beta-catenin staining are all associated with malignant meningiomas.4,8
RT. Small animal meningiomas: The information explosion tackles a challenging
disease head on. Vet J. 2012;192:135136.
2. Cantile C,
Youssef S. Nervous system. In: Maxie, MG, ed. Jubb, Kennedy, and Palmers
Pathology of Domestic Animals, Vol I. 6th ed. Philadelphia, PA: Elsevier
Ltd; 2016:396-398, 494.
3. Higgins RJ,
Bollen AW, Dickinson PJ, Siso-Llonch S. Tumors of the nervous system. In:
Meuten DJ, ed. Tumors in Domestic Animal, 5th Ed. Ames, IA:
John Wiley and Sons Inc; 2017:864-869.
4. Ide T, Uchida K,
et al. Expression of cell adhesion
molecules and doublecortin in canine anaplastic meningiomas. Vet Pathol.
A, Bilzer T, Fatzer R. Histological classification of tumors of the nervous
system of domestic animals. In: Koestner, A., Bilzer, T., Fatzer, R. eds. Histological
Classification of Tumors of the Nervous System of Domestic Animals WHO International
Classification of Tumors of Domestic Animals, Vol. 5. Washington, DC: Armed
Forces Institute of Pathology, 1999: 22.
6. Miller AD and
Zachary JF: Nervous system. In: Zachary JF, ed. Pathologic Basis of
Veterinary Disease. 6th ed. St. Louis, MO: Mosby, Inc.; 2017:874.
L, Mandara MT, Skerritt GC. Canine and feline intracranial meningiomas: An
updated review. Vet J. 2012; 192:153165.
8. Ramos-Vara JA,
Miller MA, Gilbreath E, Patterson JS. Immuno-histochemical detection of CD34,
E-cadherin, claudin-1, glucose transporter 1, laminin, and protein gene product
9.5 in 28 canine and 8 feline meningiomas. Vet Pathol.
JM., Shofer FS, Van Winkle TJ, Massicotte C. Canine Intracranial Primary
Neoplasia: 173 Cases (19862003). J Vet Intern Med. 2006; 20: 669675.
BP.Eye and ear. In: Maxie MG, ed. Jubb, Kennedy and Palmers Pathology of
Domestic Animals. Vol 1. 5th ed. Philadelphia, PA: Elsevier; 2007:518.